Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve Un-Audited financial results (Standalone and Consolidated) for the quarter and half year ended 30.09.2023.